These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 22843710)
1. Polycomb (PcG) proteins, BMI1 and SUZ12, regulate arsenic-induced cell transformation. Kim HG; Kim DJ; Li S; Lee KY; Li X; Bode AM; Dong Z J Biol Chem; 2012 Sep; 287(38):31920-8. PubMed ID: 22843710 [TBL] [Abstract][Full Text] [Related]
2. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Kotake Y; Cao R; Viatour P; Sage J; Zhang Y; Xiong Y Genes Dev; 2007 Jan; 21(1):49-54. PubMed ID: 17210787 [TBL] [Abstract][Full Text] [Related]
3. A novel zinc finger protein Zfp277 mediates transcriptional repression of the Ink4a/arf locus through polycomb repressive complex 1. Negishi M; Saraya A; Mochizuki S; Helin K; Koseki H; Iwama A PLoS One; 2010 Aug; 5(8):e12373. PubMed ID: 20808772 [TBL] [Abstract][Full Text] [Related]
4. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence. Agherbi H; Gaussmann-Wenger A; Verthuy C; Chasson L; Serrano M; Djabali M PLoS One; 2009 May; 4(5):e5622. PubMed ID: 19462008 [TBL] [Abstract][Full Text] [Related]
5. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Bruggeman SW; Hulsman D; Tanger E; Buckle T; Blom M; Zevenhoven J; van Tellingen O; van Lohuizen M Cancer Cell; 2007 Oct; 12(4):328-41. PubMed ID: 17936558 [TBL] [Abstract][Full Text] [Related]
6. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells. Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172 [TBL] [Abstract][Full Text] [Related]
7. MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1. Voncken JW; Niessen H; Neufeld B; Rennefahrt U; Dahlmans V; Kubben N; Holzer B; Ludwig S; Rapp UR J Biol Chem; 2005 Feb; 280(7):5178-87. PubMed ID: 15563468 [TBL] [Abstract][Full Text] [Related]
8. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837 [TBL] [Abstract][Full Text] [Related]
9. Bmi1 is required for hepatic progenitor cell expansion and liver tumor development. Fan L; Xu C; Wang C; Tao J; Ho C; Jiang L; Gui B; Huang S; Evert M; Calvisi DF; Chen X PLoS One; 2012; 7(9):e46472. PubMed ID: 23029524 [TBL] [Abstract][Full Text] [Related]
10. UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity. Bordeleau ME; Aucagne R; Chagraoui J; Girard S; Mayotte N; Bonneil E; Thibault P; Pabst C; Bergeron A; Barabé F; Hébert J; Sauvageau M; Boutonnet C; Meloche S; Sauvageau G Blood; 2014 Oct; 124(15):2362-9. PubMed ID: 25185265 [TBL] [Abstract][Full Text] [Related]
11. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice. Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475 [TBL] [Abstract][Full Text] [Related]
12. Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer. Becker M; Korn C; Sienerth AR; Voswinckel R; Luetkenhaus K; Ceteci F; Rapp UR PLoS One; 2009; 4(1):e4230. PubMed ID: 19156217 [TBL] [Abstract][Full Text] [Related]
13. Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes. Oguro H; Yuan J; Tanaka S; Miyagi S; Mochizuki-Kashio M; Ichikawa H; Yamazaki S; Koseki H; Nakauchi H; Iwama A J Exp Med; 2012 Mar; 209(3):445-54. PubMed ID: 22351929 [TBL] [Abstract][Full Text] [Related]
14. Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus. Liu Y; Liu F; Yu H; Zhao X; Sashida G; Deblasio A; Harr M; She QB; Chen Z; Lin HK; Di Giandomenico S; Elf SE; Yang Y; Miyata Y; Huang G; Menendez S; Mellinghoff IK; Rosen N; Pandolfi PP; Hedvat CV; Nimer SD Sci Signal; 2012 Oct; 5(247):ra77. PubMed ID: 23092893 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF. Kranc KR; Bamforth SD; Bragança J; Norbury C; van Lohuizen M; Bhattacharya S Mol Cell Biol; 2003 Nov; 23(21):7658-66. PubMed ID: 14560011 [TBL] [Abstract][Full Text] [Related]
16. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Pietersen AM; Horlings HM; Hauptmann M; Langerød A; Ajouaou A; Cornelissen-Steijger P; Wessels LF; Jonkers J; van de Vijver MJ; van Lohuizen M Breast Cancer Res; 2008; 10(6):R109. PubMed ID: 19099573 [TBL] [Abstract][Full Text] [Related]
18. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors. Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557 [TBL] [Abstract][Full Text] [Related]
19. BMI1 represses Ink4a/Arf and Hox genes to regulate stem cells in the rodent incisor. Biehs B; Hu JK; Strauli NB; Sangiorgi E; Jung H; Heber RP; Ho S; Goodwin AF; Dasen JS; Capecchi MR; Klein OD Nat Cell Biol; 2013 Jul; 15(7):846-52. PubMed ID: 23728424 [TBL] [Abstract][Full Text] [Related]
20. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance. Hinz S; Kempkensteffen C; Christoph F; Krause H; Schrader M; Schostak M; Miller K; Weikert S Tumour Biol; 2008; 29(5):323-9. PubMed ID: 18984978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]